Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions
1Department of Neurology, Brain Research Institute, Molecular Biology Institute, University of California, Los Angeles, CA, 90095, USA.
Abstract:
Formation of Aβ oligomers and fibrils plays a central role in the pathogenesis of Alzheimer's disease. There are two major forms of Aβ in the brain: Aβ42 and Aβ40. Aβ42 is the major component of the amyloid plaques, but the overall abundance of Aβ40 is several times that of Aβ42. In vitro experiments show that Aβ42 and Aβ40 affect each other's aggregation. In mouse models of Alzheimer's disease, overexpression of Aβ40 has been shown to reduce the plaque pathology, suggesting that Aβ42 and Aβ40 also interact in vivo. Here we address the question of whether Aβ42 and Aβ40 interact with each other in the formation of oligomers using electron paramagnetic resonance (EPR) spectroscopy. When the Aβ42 oligomers were formed using only spin-labeled Aβ42, the dipolar interaction between spin labels that are within 20 Å range broadened the EPR spectrum and reduced its amplitude. Oligomers formed with a mixture of spin-labeled Aβ42 and wild-type Aβ42 gave an EPR spectrum with higher amplitude due to weakened spin-spin interactions, suggesting molecular mixing of labeled and wild-type Aβ42. When spin-labeled Aβ42 and wild-type Aβ40 were mixed to form oligomers, the resulting EPR spectrum also showed reduced amplitude, suggesting that wild-type Aβ40 can also form oligomers with spin-labeled Aβ42. Therefore, our results suggest that Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions. Our results point to the importance of investigating Aβ42-Aβ40 interactions in the brain for a complete understanding of Alzheimer's pathogenesis and therapeutic interventions.
Insights
Alzheimer's disease involves amyloid-beta (Aβ) oligomers. This study shows that Aβ42 and Aβ40 peptides interact and form mixed oligomers, impacting Alzheimer's disease pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's disease pathogenesis involves amyloid-beta (Aβ) oligomers and fibrils.
- Aβ42 is a major component of amyloid plaques, while Aβ40 is more abundant in the brain.
- In vitro and in vivo studies suggest interactions between Aβ42 and Aβ40.
Purpose of the Study:
- To investigate the interaction between Aβ42 and Aβ40 during oligomer formation.
- To determine if Aβ42 and Aβ40 form mixed oligomers.
Main Methods:
- Utilized electron paramagnetic resonance (EPR) spectroscopy.
- Employed spin-labeled Aβ42 and wild-type Aβ42/Aβ40 peptides.
- Analyzed EPR spectral changes to infer molecular interactions.
Main Results:
- EPR spectra indicated molecular mixing when spin-labeled Aβ42 was combined with wild-type Aβ42.
- Reduced EPR spectral amplitude when spin-labeled Aβ42 was mixed with wild-type Aβ40 suggested Aβ40 incorporation into oligomers.
- Results demonstrate that Aβ42 and Aβ40 form mixed oligomers.
Conclusions:
- Aβ42 and Aβ40 directly interact and form mixed oligomers.
- Understanding these Aβ42-Aβ40 interactions is crucial for Alzheimer's disease pathogenesis research.
- Further investigation into Aβ42-Aβ40 brain interactions is vital for therapeutic strategies.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer's Disease: Treatment


